Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by pennyDoctoron Dec 06, 2019 6:55pm

204 Views

Post# 30430910

Potential Suitor for Sirona

Bio-Techne

Recombant Protiens and Glyco Protiens are an important part of this company's aquisition trail in the past 3 years.
You can read about the company here.
https://investors.bio-techne.com/company-information
The history of growth of the company into a $8Billion company
https://www.bio-techne.com/about/history
I am particularly impressed by the number of companies merged or purchased in the past 3 years.

If this company is shopping I may be selling!

Bullboard Posts

A Look into the Future of Chronic Pain Management